James Kimmel, Jr., is a lecturer of psychiatry at the Yale School of Medicine, a lawyer, and the founder and co-director of the Yale Collaborative for Motive Control Studies. He is the creator of The ...

President Donald Trump on Monday signed into law a measure authorizing billions of dollars in federal funding to help prevent ...

In fact, they found it to work even better than the current most-effective drug for treating alcoholism on the market. According to the National Institute on Alcohol Abuse and Alcoholism, over 28 ...

COPENHAGEN, March 6 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab will explore how GLP-1 drugs could help patients struggling with addiction, its head of development Martin Holst Lange told an ...

A coalition of addiction experts said more than 300 physicians, harm reduction workers and researchers signed a letter delivered to Congress late on Monday warning of "dire consequences" if the U.S.

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...